Glimiheal MP 2mg/500mg/15mg Tablet SR
Marketer
Healing India Life Sciences
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimiheal MP 2mg/500mg/15mg Tablet SR
Combiflex DM 2mg/500mg/15mg Extended-Release Tablets are a triple-combination medication designed for blood glucose management. In adults with type 2 diabetes, this medication, used alongside diet and exercise, enhances glycemic control. It facilitates improved insulin utilization, thus reducing blood sugar. Always adhere to your doctor's prescribed dosage and frequency for Combiflex DM 2mg/500mg/15mg ER Tablets. Taking it with food minimizes potential stomach discomfort. Missed doses should be taken as soon as remembered, unless nearing the next scheduled dose; in that case, omit the missed dose and resume your regular regimen. Never double the dose. Overdosage can cause hypoglycemia (low blood sugar). Concurrent use with other antidiabetic medications, alcohol consumption, or skipped meals may increase the risk of hypoglycemia. Regular blood sugar monitoring is essential. Common side effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and upper respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your physician. Pregnant or lactating individuals should seek medical counsel before use. Kidney function tests will be assessed by your doctor before initiating therapy. Limit alcohol consumption during treatment to mitigate potential side effect risks.
Uses of Glimiheal MP 2mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glimiheal MP 2mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimiheal MP 2mg/500mg/15mg Tablet SR whole; do not break, crush, or chew it. Administer this medication with a meal.
Common Side effects of Glimiheal MP 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimiheal MP 2mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimiheal MP 2mg/500mg/15mg Tablet SR whole; do not crush, chew, or divide it. Administer this medication with food.
How Glimiheal MP 2mg/500mg/15mg Tablet SR works:
Glimiheal MP 2mg/500mg/15mg Extended-Release Tablets combine glimepiride, metformin, and pioglitazone, three distinct antidiabetic agents. This triple therapy offers enhanced blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further enhances insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimiheal MP 2mg/500mg/15mg SR tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Glimiheal MP 2mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice before using this medication.
Breast feedingCONSULT YOUR DOCTOR
Prolonged-release Glimiheal MP 2mg/500mg/15mg tablets are likely unsuitable for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively high or low blood glucose levels. Refrain from driving if you experience these conditions.
KidneyCAUTION
Exercise caution when prescribing Glimiheal MP 2mg/500mg/15mg Tablet SR to individuals with impaired renal function; dosage modification may be necessary. Severe kidney disease contraindicates the use of Glimiheal MP 2mg/500mg/15mg Tablet SR. Physician consultation is recommended. Routine monitoring of kidney function is advised during treatment with this medication.
LiverCAUTION
Patients with liver impairment should use Glimiheal MP 2mg/500mg/15mg Tablet SR cautiously, potentially requiring dosage modification. Consult a physician before use. This medication is contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Glimiheal MP 2mg/500mg/15mg Tablet SR :
Should you forget a dose of Glimiheal MP 2mg/500mg/15mg Tablet SR, take it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimiheal MP 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently